287114-32-3 Usage
General Description
1-(2-Pyridinyl)hexahydro-1H-1,4-diazepine, also known as 2-Pyridyl-1,4-hexahydropyrazine, is a chemical compound with the molecular formula C11H18N2. It is a heterocyclic compound containing a six-membered ring with alternating carbon and nitrogen atoms, as well as a pyridine ring attached to the ring. 1-(2-Pyridinyl)hexahydro-1H-1,4-diazepine has potential applications in the field of pharmaceuticals, as it exhibits biological activity against certain pathogens and can be used as a building block in the synthesis of various compounds. Its unique structure gives it the potential to act as a versatile intermediate in organic synthesis and drug discovery research.
Check Digit Verification of cas no
The CAS Registry Mumber 287114-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,1,1 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 287114-32:
(8*2)+(7*8)+(6*7)+(5*1)+(4*1)+(3*4)+(2*3)+(1*2)=143
143 % 10 = 3
So 287114-32-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H15N3/c1-2-6-12-10(4-1)13-8-3-5-11-7-9-13/h1-2,4,6,11H,3,5,7-9H2
287114-32-3Relevant articles and documents
METHOD FOR USE OF HOMOPIPERAZINIUM COMPOUNDS IN THE TREATMENT OF CANCER
-
Page/Page column 11; 12, (2015/11/17)
The present disclosure relates to a method for treating cancer comprising administering to a patient in need thereof an effective amount of a compound having the formula: (Formula (I)) wherein R1, R2, Ya, Xa, and J- are as defined herein.
CXCR4 Receptor Antagonists
-
Paragraph 0376; 0377, (2013/11/06)
Disclosed are compounds that are antagonists of the CXCR4 receptor.
THIENOPYRIDINE DERIVATIVES
-
Page/Page column 136, (2010/11/26)
The present invention provides a compound promoting osteogenesis. The present invention provides a compound having the following general formula (I) wherein R 1 is H or alkyl, R 2 is R a S-, R a O-, R a NH-, R a (R b )N- or cyclic amino, and R a and R b are alkyl which may be substituted, cycloalkyl which may be substituted, or the like, or a pharmacologically acceptable salt thereof.